Repository logo

Statistics for A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND)

Total visits

views
A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND) 122

Total visits per month

views
August 2024 3
September 2024 4
October 2024 10
November 2024 4
December 2024 3
January 2025 0
February 2025 0

File Visits

views
Chronic Diabetic Macular Edema.pdf(legacy) 236
Chronic Diabetic Macular Edema.pdf 3

Top country views

views
United States 50
China 29
Portugal 13
Australia 11
India 6
France 3
Brazil 2
Canada 2
Germany 2
South Korea 1
Sweden 1

Top city views

views
Durg 1